Navigation Links
New Diarrhoea Bug Warning in Australia

Australia must prepare for the possible outbreak of a highly infectious strain of a diarrhoea-causing organism, scientists have warned in the latest issue// of the Medical Journal of Australia (MJA).

Clostridium difficile (C. difficile) is the most commonly diagnosed cause of infectious hospital-acquired diarrhoea in developed countries, including Australia.

Canada, Europe, and the US have all recently seen sudden increases in rates of C. difficile infection and high mortality rates, with people over 65 years of age being most at risk, suggesting the emergence of a highly virulent strain of C. difficile.

Professor Thomas Riley, Professor in Microbiology and Immunology at the University of Western Australia, outlines the characteristics of the various strains of C. difficile.

"Acquisition of C. difficile is facilitated by its ability to form spores that are resistant to many disinfectants, so that it remains viable in the hospital environment for long periods of time," says Prof Riley.

He adds that C. difficile strains have also shown resistance to one group of antibiotics (fluoroquinolones), possibly through overuse of these medications.

The virulent strain cannot be differentiated from other strains without molecular typing, which makes it difficult to know whether the organism has reached Australia's shores.

He says many laboratories in Australia, to save money and time, are using a testing technology that may not detect the virulent C. difficile strain.

Prof Riley recommends targeted surveillance, with one or two laboratories being funded periodically to test samples from a number of different hospitals.

"The value of sensible policies regarding antibiotic use, and good infection control staff and procedures, cannot be over emphasised," he says.

"In the long term, such initiatives are likely to have an impact not only on C. difficile-associated diarrhoea but also on other infection control problem organisms."


'"/>




Related medicine news :

1. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
2. Deadly Diarrhoea Vaccine – Trail Results Promising
3. Health Department Geared Up To Meet Diarrhoea Cases
4. Child Diarrhoea Due To Rotavirus:Quick Relief By Short Course Drug
5. Students of Dharamsala Hospitalized for Diarrhoea
6. Early Warning System For Breast Cancer
7. Warning on radiowave exposure
8. A Seizure Late In Life Could be A Stroke Warning
9. Blood Pressure An Early Warning Sign Of Alzheimer’s Disease
10. Early Warning Signs Of Heart Disease
11. Warning Issued by FDA on consumption of the drug Tysabri used to treat Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Thank you to all who ... 8-10. , This event was exclusive to providers and offered an opportunity to ... took place at the Manchester Grand Hyatt where attendees gathered for a lively discussion ...
(Date:3/28/2017)... ... , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A ... his parents and teachers had asked of him that he had neglected to do, but ... the Almighty Creator. There were some who would have felt themselves to be special and ...
(Date:3/27/2017)... ... ... New patients who have sleep apnea in Aurora, CO, can now ... Sleep apnea is often left untreated because patients are not familiar with common symptoms ... , Dr. Braasch seeks to raise awareness of sleep apnea in Aurora, CO, and ...
(Date:3/27/2017)... WI (PRWEB) , ... March 27, 2017 , ... ... new patients for custom smile makeovers without requiring a referral. Trimble ... orthodontics, gum disease treatment, cosmetic dentistry and dental implants. Whether patients have discolored, ...
(Date:3/27/2017)... ... 27, 2017 , ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope ... the key role this treatment plays in protecting oral health, along with the benefits ... those who need a root canal in White Plains, NY or their second location ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
(Date:3/27/2017)... LightIntegra Technology Inc. today announced that its ... President and Chief Executive Officer effective March 13, 2017. ... Directors of LightIntegra. Paul Geyer will continue ... "This is the perfect time for Bill ... We,ve selected a very strong leader at a time ...
(Date:3/27/2017)...  A new survey from the American ... Bidding Program (CBP) significantly reduced beneficiary choice and access ... choice forces beneficiaries to switch to unfamiliar or unsuitable ... AADE,s survey is the latest in a ... out the inherent problems with the CBP. Last year, ...
Breaking Medicine Technology: